Experience with Hydroxycarbamide Use: Indications, Adverse effects and clinical course at a Tertiary Care Hospital in Lagos.

Simple item page
dc.contributor.authorAkinsete, A.M.
dc.contributor.authorAwofeso, O.M.
dc.contributor.authorAkagu, J.
dc.contributor.authorOnyia, S.
dc.contributor.authorAkinsulie, A.A.
dc.contributor.authorTemiye, E. O.
dc.date.accessioned2019-12-10T13:24:16Z
dc.date.available2019-12-10T13:24:16Z
dc.date.issued2018-01
dc.descriptionStaff publicationsen_US
dc.description.abstractSickle cell disease is the most common inherited hemoglobin disorder with the highest prevalence in sb-Saharan Africa. The clinical course of the disease has improved with newborn screening, penicillin prophylaxis and hydroxycarbamide use amongst other interventions. Despite the data on the benefit of hydroxycarbamide use, the uptake of hydroxycarbamide in poor resource settings is still very low. This was a retrospective study at the Lagos University Teaching Hospital from January to December 2017 among children with sickle cell anemia on hydroxycarbamide. Ethical approval was obtained from the Health, Research and Ethics committee of the Hospital. Statistical analysis was with SPSS version 20. A total of 1039 children were seen in the period under review with 13.5% of them on hydroxycarbamide. The commonest indication for hydroxycarbamide use was high risk for stroke while lumbar infarction was the least common indication. Adverse effects were seen in 2.1% of the recipients and all these patients had derangements of liver function. None of the recipients had hematologic adverse effects The use of hydroxycarbamide is relatively safe among children living in resource constrained settings but long term follow-up among a large cohort is desired.en_US
dc.identifier.citationAkinsete AM, Awofeso OM, Akagu J, Onyia S, Akinsulie A, Temiye E. Experience with Hydroxycarbamide Use: Indications, Adverse effects and clinical course at a Tertiary Care Hospital in Lagos. Nigeria Quarterly Journal of Hospital Medicine. 2018 January; 28(1):26 - 30.en_US
dc.identifier.urihttps://ir.unilag.edu.ng/handle/123456789/7065
dc.language.isoenen_US
dc.publisherLagos University Medical Societyen_US
dc.relation.ispartofseriesNigeria Quarterly Journal of Hospital Medicine;Vol.28(1)
dc.subjecthydroxycarbamide experience indications clinical courseen_US
dc.subjectSickle cell diseaseen_US
dc.subjecthemoglobin disorderen_US
dc.subjectHydroxycarbamide useen_US
dc.subjectChildrenen_US
dc.titleExperience with Hydroxycarbamide Use: Indications, Adverse effects and clinical course at a Tertiary Care Hospital in Lagos.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Hydroxycarbamide article.pdf
Size:
979.82 KB
Format:
Adobe Portable Document Format
Description:
Main article
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Paediatrics- Scholarly Publications